Unternehmen
Regeneron Pharmaceuticals, Inc

Aktueller Kurs
517.93 USD

Symbol
REGN

ISIN
US75886F1075

Börse
NASDAQ

Sektor
Health Care

Marktkapitalisierung
55.2662 Mrd. US

Branche
Biotechnology

Dividendenrendite
0 %

Ausschüttungsquote
0 %

KGV
18.98

KUV (TTM)
6.02

KGVe
12.15

Kursziel
659.52 USD

Unternehmen
Regeneron Pharmaceuticals, Inc

Aktueller Kurs
517.93 USD

Symbol
REGN

ISIN
US75886F1075

Börse
NASDAQ

Marktkapitalisierung
55.2662 Mrd. USD

Sektor
Health Care

Branche
Biotechnology

Dividendenrendite
0 %

Ausschüttungsquote
0 %

KGV
18.98

KUV (TTM)
6.02

KGVe
12.15

Kursziel
659.52 USD

Live-Chart (verzögert)

Firmenbeschreibung

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis in adults, and asthma in adults and adolescents; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; and Kevzara solution for subcutaneous injection for treating rheumatoid arthritis in adults. In addition, the company offers Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer. Further, it is developing various product candidates for treating patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases, and other diseases. The company has collaboration and license agreements with Sanofi; Bayer; Teva; Mitsubishi Tanabe Pharma; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Vyriad, Inc., as well as has an agreement with the U.S. Department of Health and Human Services. It has collaborations with Zai Lab Limited; Intellia Therapeutics, Inc.; and BioNTech. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.

Regeneron Pharmaceuticals, Inc Fundamentaldaten

Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)

Das Geschäftsjahr von Regeneron Pharmaceuticals, Inc endet im Dezember.

Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 0.625 0.897 0.842 0.000 2.364
2019 0.461 0.193 0.670 0.792 2.116
2018 0.478 0.551 0.595 0.820 2.444
2017 0.249 0.388 0.388 0.174 1.199
2016 0.166 0.196 0.265 0.269 0.896
2015 0.076 0.195 0.210 0.155 0.636
2014 0.068 0.093 0.083 0.110 0.355
2013 0.099 0.087 0.141 0.097 0.424
2012 0.012 0.077 0.191 0.470 0.750
2011 -0.043 -0.063 -0.062 -0.053 -0.222
2010 0.000 -0.025 -0.034 0.000 -0.059

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 6.6 7.16 8.36 0 22.12
2019 4.45 6.02 6.67 7.5 24.64
2018 4.67 5.45 5.87 6.84 22.83
2017 2.92 4.17 3.99 5.23 16.31
2016 2.57 2.82 3.13 3.04 11.56
2015 2.88 2.89 3.47 2.83 12.07
2014 2.26 2.47 2.52 2.79 10.04
2013 0.9 0.79 1.25 0.86 3.8
2012 0.16 0.7 1.72 1.22 3.8
2011 -0.49 -0.69 -0.68 -0.54 -2.4
2010 -0.38 -0.31 -0.41 -0.17 -1.27

Umsatz pro Jahr & Quartal in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 1.8282 1.952 2.294 0 6.0742
2019 1.7118 1.9337 2.0484 2.1695 7.8634
2018 1.51148 1.60802 1.6635 1.9278 6.7108
2017 1.31899 1.47012 1.50067 1.58245 5.87223
2016 1.20085 1.21263 1.22012 1.22683 4.86043
2015 0.869612 0.998617 1.13742 1.09808 4.10373
2014 0.62574 0.6657 0.725788 0.802329 2.81956
2013 0.439664 0.457642 0.597027 0.610412 2.10474
2012 0.231789 0.304399 0.427687 0.414602 1.37848
2011 0.112204 0.10781 0.102833 0.122977 0.445824
2010 0.103534 0.115886 0.105979 0.133675 0.459074

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 15.90 16.54 20.12 0.00 43.39
2019 14.76 16.81 17.97 18.87 68.38
2018 13.14 13.98 14.47 16.76 58.35
2017 11.47 12.67 12.83 13.64 50.62
2016 10.53 10.45 10.52 10.58 41.90
2015 7.56 8.68 9.81 9.55 35.68
2014 5.59 5.89 6.20 7.10 24.95
2013 4.03 4.12 5.10 5.50 18.96
2012 2.15 2.77 3.69 3.61 11.99
2011 1.26 1.20 1.13 1.35 4.90
2010 1.28 1.43 1.29 1.61 5.53

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 -21.14 43.66 -6.15 -100.00 11.73
2019 -43.79 -58.12 246.76 18.28 -13.44
2018 175.46 15.36 7.84 37.95 103.95
2017 -7.38 55.76 0.15 -55.32 33.83
2016 6.93 18.39 34.95 1.50 40.79
2015 -31.00 156.04 8.09 -26.33 79.38
2014 -29.44 35.77 -10.09 32.15 -16.44
2013 -78.98 -11.63 61.72 -31.49 -43.44
2012 0.00 558.68 149.49 145.68 0.00
2011 0.00 0.00 0.00 0.00 0.00
2010 0.00 0.00 0.00 0.00 0.00

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 -15.73 6.77 17.52 0.00 0.00
2019 -11.20 12.96 5.93 5.91 17.18
2018 -4.48 6.39 3.45 15.89 14.28
2017 7.51 11.46 2.08 5.45 20.82
2016 9.36 0.98 0.62 0.55 18.44
2015 8.39 14.83 13.90 -3.46 45.55
2014 2.51 6.39 9.03 10.55 33.96
2013 6.04 4.09 30.46 2.24 52.69
2012 88.48 31.33 40.50 -3.06 209.20
2011 -16.06 -3.92 -4.62 19.59 -2.89
2010 6.96 11.93 -8.55 26.13 21.04

Regeneron Pharmaceuticals, Inc Fundamentaldaten

Gewinn pro Jahr & Quartal (Net Income)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 0.625 0.897 0.842 0.000 2.364
2019 0.461 0.193 0.670 0.792 2.116
2018 0.478 0.551 0.595 0.820 2.444
2017 0.249 0.388 0.388 0.174 1.199
2016 0.166 0.196 0.265 0.269 0.896
2015 0.076 0.195 0.210 0.155 0.636
2014 0.068 0.093 0.083 0.110 0.355
2013 0.099 0.087 0.141 0.097 0.424
2012 0.012 0.077 0.191 0.470 0.750
2011 -0.043 -0.063 -0.062 -0.053 -0.222
2010 0.000 -0.025 -0.034 0.000 -0.059

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 6.6 7.16 8.36 0 22.12
2019 4.45 6.02 6.67 7.5 24.64
2018 4.67 5.45 5.87 6.84 22.83
2017 2.92 4.17 3.99 5.23 16.31
2016 2.57 2.82 3.13 3.04 11.56
2015 2.88 2.89 3.47 2.83 12.07
2014 2.26 2.47 2.52 2.79 10.04
2013 0.9 0.79 1.25 0.86 3.8
2012 0.16 0.7 1.72 1.22 3.8
2011 -0.49 -0.69 -0.68 -0.54 -2.4
2010 -0.38 -0.31 -0.41 -0.17 -1.27

Umsatz pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 1.8282 1.952 2.294 0 6.0742
2019 1.7118 1.9337 2.0484 2.1695 7.8634
2018 1.51148 1.60802 1.6635 1.9278 6.7108
2017 1.31899 1.47012 1.50067 1.58245 5.87223
2016 1.20085 1.21263 1.22012 1.22683 4.86043
2015 0.869612 0.998617 1.13742 1.09808 4.10373
2014 0.62574 0.6657 0.725788 0.802329 2.81956
2013 0.439664 0.457642 0.597027 0.610412 2.10474
2012 0.231789 0.304399 0.427687 0.414602 1.37848
2011 0.112204 0.10781 0.102833 0.122977 0.445824
2010 0.103534 0.115886 0.105979 0.133675 0.459074

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 15.90 16.54 20.12 0.00 43.39
2019 14.76 16.81 17.97 18.87 68.38
2018 13.14 13.98 14.47 16.76 58.35
2017 11.47 12.67 12.83 13.64 50.62
2016 10.53 10.45 10.52 10.58 41.90
2015 7.56 8.68 9.81 9.55 35.68
2014 5.59 5.89 6.20 7.10 24.95
2013 4.03 4.12 5.10 5.50 18.96
2012 2.15 2.77 3.69 3.61 11.99
2011 1.26 1.20 1.13 1.35 4.90
2010 1.28 1.43 1.29 1.61 5.53

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 -21.14 43.66 -6.15 -100.00 11.73
2019 -43.79 -58.12 246.76 18.28 -13.44
2018 175.46 15.36 7.84 37.95 103.95
2017 -7.38 55.76 0.15 -55.32 33.83
2016 6.93 18.39 34.95 1.50 40.79
2015 -31.00 156.04 8.09 -26.33 79.38
2014 -29.44 35.77 -10.09 32.15 -16.44
2013 -78.98 -11.63 61.72 -31.49 -43.44
2012 0.00 558.68 149.49 145.68 0.00
2011 0.00 0.00 0.00 0.00 0.00
2010 0.00 0.00 0.00 0.00 0.00

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 -15.73 6.77 17.52 0.00 0.00
2019 -11.20 12.96 5.93 5.91 17.18
2018 -4.48 6.39 3.45 15.89 14.28
2017 7.51 11.46 2.08 5.45 20.82
2016 9.36 0.98 0.62 0.55 18.44
2015 8.39 14.83 13.90 -3.46 45.55
2014 2.51 6.39 9.03 10.55 33.96
2013 6.04 4.09 30.46 2.24 52.69
2012 88.48 31.33 40.50 -3.06 209.20
2011 -16.06 -3.92 -4.62 19.59 -2.89
2010 6.96 11.93 -8.55 26.13 21.04

Regeneron Pharmaceuticals, Inc Dividenden-Entwicklung

Ex-Tag Record Date Zahltag Dividende
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0